HBM Holdings enters strategic biologics R&D collaboration with SinopharmPUBT·1 day ago, 04:00 AM01099+0.47%02142-1.74%
HBM Holdings Flags Strong Interim Earnings on Pharma PartnershipsTip Ranks·Jul 23 at 07:07 PM02142-1.74%
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable GrowthPR Newswire·Jul 23 at 07:02 PM02142-1.74%BMY0.00%
20:55 ETNona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseasesprnewswire·Jul 22 at 07:56 PM02142-1.74%
Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapyPharmaceutical Technology·Jul 16 at 03:59 AM06990-0.97%02142-1.74%
China NMPA clears Kelun-Biotech, Harbour BioMed asthma IND for SKB575/HBM7575PUBT·Jul 15 at 05:02 AM06990-0.97%02142-1.74%
Harbour BioMed appoints Lloyd Klickstein scientific advisor for immunologyPUBT·Jun 28 at 08:28 PM02142-1.74%
Macro Flows Reshape HK Equities: Safe-Haven Premiums in Cross-Border Assets and Sector OutlookGlobal Report·Jun 20 at 04:24 AM01157-1.19%01276+0.96%
